thelancet.com
Jun 12, 2025, 05:36
The Lancet Haematology – Extended Anticoagulation in Children with VTE: New Insights from the EINSTEIN-Jr Trial
The Lancet Haematology shared on X:
“A cohort study within the EINSTEIN-Jr trial explores extended-phase anticoagulation for acute VTE in children:
Key factors: symptomatic index VTE, unprovoked VTE, & residual thrombosis.
Low risk of recurrent VTE & no major bleeding.”
Title: Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.
Autors: Christoph Male, Anthonie W A Lensing, Anthony K C Chan, Gili Kenet, Guy Young, Rukhmi Bhat, Akos F Pap, Dagmar Kubitza, Martin H Prins, Paul Monagle.
Here are some of the most compelling recent updates on Hemostasis Today
Akos F Pap
Anthonie W A Lensing
Anthony K C Chan
Anticoagulation Safety
Bleeding Risk in Children
Christoph Male
Dagmar Kubitza
EINSTEIN-Jr Trial
Extended-phase Anticoagulation
Gili Kenet
Guy Young
Headlines
Hemostasis Today
Martin H Prins
Paul Monagle
Pediatric Hemostasis
Pediatric Venous Thromboembolism
Recurrent Thrombosis Risk
Residual Thrombosis
Rukhmi Bhat
Symptomatic VTE
The Lancet Haematology
Unprovoked VTE in Children
-
Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
-
Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
-
Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
-
Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
-
Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
-
Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry
Nov 3, 2025, 09:13
Nov 3, 2025, 08:23
Nov 3, 2025, 07:10
Nov 3, 2025, 04:56